Balyasny Asset Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.3 - $3.58 $44,762 - $123,270
34,433 New
34,433 $82,000
Q4 2022

Feb 14, 2023
BUY
$1.8 - $2.56 $69,078 - $98,245
38,377 New
38,377 $73,000
Q2 2022

Aug 15, 2022
BUY
$1.31 - $2.69 $21,435 - $44,016
16,363 New
16,363 $30,000
Q4 2018

Feb 14, 2019
SELL
$6.15 - $10.51 $638,007 - $1.09 Million
-103,741 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$10.32 - $13.06 $1.07 Million - $1.35 Million
103,741 New
103,741 $1.11 Million

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email